Feasibility of PET/CT system performance harmonisation for quantitative multicentre 89Zr studies

被引：0
|
作者：
Andres Kaalep
Marc Huisman
Terez Sera
Danielle Vugts
Ronald Boellaard
机构：
[1] North Estonia Medical Centre Foundation,Department of Medical Technology
[2] VU University Medical Center,Department of Radiology and Nuclear Medicine
[3] University of Szeged,Department of Nuclear Medicine
[4] University of Groningen,Department of Nuclear Medicine and Molecular Imaging
[5] University Medical Center Groningen,undefined
[6] EANM Research Limited (EARL),undefined
[7] EATRIS ERIC (European Infrastructure for Translational Medicine),undefined
[8] TRISTAN-IMI consortium (Translational Imaging in Drug Safety Assessment - Innovative Medicines Initiative),undefined
来源：
EJNMMI Physics | / 5卷
关键词：
Zr; Performance; Harmonisation; PET/CT; Quantification; EARL accreditation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Cyclotron Produced 89Zr, A Potential Radiotracer for Immuno-PET
    Khandaker, Mayeen Uddin
    Kim, Kwangsoo
    Lee, Manwoo
    Kim, Kyung Sook
    Kim, Guinyun
    [J]. 2012 NATIONAL PHYSICS CONFERENCE (PERFIK 2012), 2013, 1528 : 395 - 399
  • [42] 89Zr immuno-PET:: Comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies
    Verel, I
    Visser, GWM
    Boellaard, R
    Stigter-van Walsum, M
    Snow, GB
    van Dongen, GAMS
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (08) : 1271 - 1281
  • [43] 89Zr Labelled Self-assembled nanoparticles for PET imaging
    Wang, Xinyu
    Pan, Donghui
    Yang, Min
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [44] Will Denoising 89Zr Atezolizumab PET/CT Images Help Interpretation? A Reader Study from Radiologists' Perspective
    Qi, Jin
    Alvarado, Sergio
    Philips, Elizeva
    Qin, Qian
    Brugarolas, James
    Dakanali, Marianna
    Mulgaonkar, Aditi
    Sun, Xiankai
    Oz, Orhan
    Bowen, Spencer
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [45] Toward Optimized 89Zr-Immuno-PET: Side-by-Side Comparison of [89Zr]Zr-DFO-, [89Zr]Zr-3,4,3-(LI-1,2-HOPO)- and [89Zr]Zr-DFO*-Cetuximab for Tumor Imaging: Which Chelator Is the Most Suitable?
    Damerow, Helen
    Cheng, Xia
    von Kiedrowski, Valeska
    Schirrmacher, Ralf
    Waengler, Bjoern
    Fricker, Gert
    Waengler, Carmen
    [J]. PHARMACEUTICS, 2022, 14 (10)
  • [46] Optimization of 89Zr PET imaging using both phantom and clinical studies with [89Zr]-Df-IAB22M2C, an anti-CD8 minibody
    Daube-Witherspoon, Margaret
    Farwell, Michael
    Sunderland, John
    Viswanath, Varsha
    Korn, Ronald
    Wilson, Ian
    Karp, Joel
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [47] Design and efficient synthesis of a bifunctional octadentate ligand for PET imaging with 89Zr
    Abdalrahman, Mahmoud
    Planalp, Roy
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [48] Glypican-3-Targeted 89Zr PET Imaging of Hepatocellular Carcinoma
    Sham, Jonathan G.
    Kievit, Forrest M.
    Grierson, John R.
    Miyaoka, Robert S.
    Yeh, Matthew M.
    Zhang, Miqin
    Yeung, Raymond S.
    Minoshima, Satoshi
    Park, James O.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (05) : 799 - 804
  • [49] Manufacture of 89Zr Radiolabeled Protein, 89Zr-DFO-Transferrin, for IND Enabling Studies.
    Lyashchenko, Serge
    Henry, Kelly
    Staton, Kevin
    Evans, Michael
    Holland, Jason
    Lewis, Jason S.
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2017, 60 : S345 - S345
  • [50] Production, quality control of next-generation PET nuclide zirconium-89 (89Zr)
    Wang, Feng
    Yang, Zhi
    Zhu, Hua
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S565 - S566
12345